» Articles » PMID: 12059909

Delayed Toxicity of Cyclophosphamide on the Bladder of DBA/2 and C57BL/6 Female Mouse

Overview
Publisher Wiley
Specialty Pathology
Date 2002 Jun 13
PMID 12059909
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The present study describes the delayed development of a severe bladder pathology in a susceptible strain of mice (DBA/2) but not in a resistant strain (C57BL/6) when both were treated with a single 300 mg/kg dose of cyclophosphamide (CY). Inbred DBA/2 and C57BL/6 female mice were injected with CY, and the effect of the drug on the bladder was assessed during 100 days by light microscopy using different staining procedures, and after 30 days by conventional electron microscopy. Early CY toxicity caused a typical haemorrhagic cystitis in both strains that was completely repaired in about 7-10 days. After 30 days of CY injection ulcerous and non-ulcerous forms of chronic cystitis appeared in 86% of DBA/2 mice but only in 4% of C57BL/6 mice. Delayed cystitis was characterized by infiltration and transepithelial passage into the lumen of inflammatory cells and by frequent exfoliation of the urothelium. Mast cells appeared in the connective and muscular layers of the bladder at a much higher number in DBA/2 mice than in C57BL/6 mice or untreated controls. Electron microscopy disclosed the absence of the typical discoidal vesicles normally present in the cytoplasm of surface cells. Instead, numerous abnormal vesicles containing one or several dark granules were observed in the cytoplasm of cells from all the epithelial layers. Delayed cystitis still persisted in DBA/2 mice 100 days after treatment. These results indicate that delayed toxicity of CY in female DBA/2 mice causes a bladder pathology that is not observed in C57BL/6 mice. This pathology resembles interstitial cystitis in humans and could perhaps be used as an animal model for studies on the disease.

Citing Articles

NLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity.

Wei S, Ma W, Zhang B, Li W Front Cell Dev Biol. 2021; 9:634607.

PMID: 33912556 PMC: 8072389. DOI: 10.3389/fcell.2021.634607.


Keratinocyte Growth Factor Reduces Injury and Leads to Early Recovery from Cyclophosphamide Bladder Injury.

Narla S, Bushnell D, Schaefer C, Nouraie M, Bates C Am J Pathol. 2019; 190(1):108-124.

PMID: 31654636 PMC: 6943803. DOI: 10.1016/j.ajpath.2019.09.015.


Immune Relevant and Immune Deficient Mice: Options and Opportunities in Translational Research.

Radaelli E, Santagostino S, Sellers R, Brayton C ILAR J. 2019; 59(3):211-246.

PMID: 31197363 PMC: 7114723. DOI: 10.1093/ilar/ily026.


Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects.

Crouch M, Knowels G, Stuppard R, Ericson N, Bielas J, Marcinek D PLoS One. 2017; 12(7):e0181086.

PMID: 28700655 PMC: 5507312. DOI: 10.1371/journal.pone.0181086.


Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models.

Cao S, Durrani F, Toth K, Rustum Y Br J Cancer. 2014; 110(7):1733-43.

PMID: 24619073 PMC: 3974093. DOI: 10.1038/bjc.2014.85.


References
1.
PHILIPS F, Sternberg S, CRONIN A, Vidal P . Cyclophosphamide and urinary bladder toxicity. Cancer Res. 1961; 21:1577-89. View

2.
Lane M . Some effects of cyclophosphamide (cytoxan) on normal mice and mice with L1210 leukemia. J Natl Cancer Inst. 1959; 23:1347-59. View

3.
Elbadawi A . Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology. 1997; 49(5A Suppl):14-40. DOI: 10.1016/s0090-4295(99)80329-x. View

4.
Koss L . A light and electron microscopic study of the effects of a single dose of cyclophosphamide on various organs in the rat. I. The urinary bladder. Lab Invest. 1967; 16(1):44-65. View

5.
Anton E, BRANDES D . Lysosomes in mice mammary tumors treated with cyclophosphamide. Distribution related to course of disease. Cancer. 1968; 21(3):483-500. DOI: 10.1002/1097-0142(196803)21:3<483::aid-cncr2820210320>3.0.co;2-6. View